| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w27520 |
| 来源ID | Working Paper 27520 |
| Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws | |
| Sumedha Gupta; Thuy D. Nguyen; Patricia R. Freeman; Kosali I. Simon | |
| 发表日期 | 2020-08-03 |
| 出版年 | 2020 |
| 语种 | 英语 |
| 摘要 | A large concern in U.S. opioid policy is whether supply side controls are effective at reducing the quantity of opioids prescribed, without harmful substitution. An unstudied way that policy targeted a major opioid through the federal Controlled Substance Act (CSA) was the August 2014 scheduling of tramadol products, the second most popular opioid medication at the time. Twelve states implemented the identical policy prior to federal action, providing a unique opportunity to compare effectiveness of the same opioid policy at state versus federal levels. This is important because many recent opioid policy interventions have only taken the form of state actions, while federal policy has largely been advisory. Seven weeks after tramadol's scheduling, the leading opioid form on the market, hydrocodone combination products, was move to the more restricted level II (no refills allowed) from level III in the CSA, allowing us to test a new question in the opioid literature: competitive spillover effects from regulations targeting one drug. Using weekly prescription data spanning 2007-2017, this study finds that tightening prescribing restrictions on one opioid leads to decreases in its use, but also causes some increases in prescriptions of close competitors, leading to no statistically detectable short-run reduction in total opioid prescriptions. |
| 主题 | Health, Education, and Welfare ; Health ; Education |
| URL | https://www.nber.org/papers/w27520 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/585269 |
| 推荐引用方式 GB/T 7714 | Sumedha Gupta,Thuy D. Nguyen,Patricia R. Freeman,et al. Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws. 2020. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w27520.pdf（3898KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
